American Banking and Market News logo

The Latest Headlines at American Banking and Market News

Image about Latham Group (NASDAQ:SWIM) Upgraded to Buy at Stifel Nicolaus

Latham Group (NASDAQ:SWIM) Upgraded to Buy at Stifel Nicolaus

Stifel Nicolaus upgraded shares of Latham Group (NASDAQ:SWIM – Free Report) from a hold rating to a buy rating in a research note released on Monday, Marketbeat.com reports. The firm currently has $4.00 price objective on the... More of this article »
Image about NIKE (NYSE:NKE) Price Target Cut to $120.00 by Analysts at Telsey Advisory Group

NIKE (NYSE:NKE) Price Target Cut to $120.00 by Analysts at Telsey Advisory Group

NIKE (NYSE:NKE – Free Report) had its price target reduced by Telsey Advisory Group from $140.00 to $120.00 in a research note issued to investors on Monday morning, Marketbeat reports. Telsey Advisory Group currently has an... More of this article »
Image about Regulus Therapeutics (NASDAQ:RGLS) Now Covered by Analysts at SVB Leerink

Regulus Therapeutics (NASDAQ:RGLS) Now Covered by Analysts at SVB Leerink

SVB Leerink initiated coverage on shares of Regulus Therapeutics (NASDAQ:RGLS – Free Report) in a research report released on Monday morning, MarketBeat.com reports. The brokerage issued an outperform rating and a $6.00 price... More of this article »
Image about PowerFleet (NASDAQ:PWFL) Coverage Initiated by Analysts at Northland Securities

PowerFleet (NASDAQ:PWFL) Coverage Initiated by Analysts at Northland Securities

Northland Securities started coverage on shares of PowerFleet (NASDAQ:PWFL – Free Report) in a research note published on Monday, MarketBeat reports. The brokerage issued an outperform rating and a $7.00 target price on the stock. Other... More of this article »
Image about Jasper Therapeutics (NASDAQ:JSPR) Now Covered by Analysts at TD Cowen

Jasper Therapeutics (NASDAQ:JSPR) Now Covered by Analysts at TD Cowen

TD Cowen assumed coverage on shares of Jasper Therapeutics (NASDAQ:JSPR – Free Report) in a research note released on Monday, Marketbeat Ratings reports. The firm issued an outperform rating on the stock. Separately, Oppenheimer... More of this article »
Image about Hibbett (NASDAQ:HIBB) Given “Market Perform” Rating at Telsey Advisory Group

Hibbett (NASDAQ:HIBB) Given “Market Perform” Rating at Telsey Advisory Group

Telsey Advisory Group reaffirmed their market perform rating on shares of Hibbett (NASDAQ:HIBB – Free Report) in a research note published on Monday, MarketBeat Ratings reports. Telsey Advisory Group currently has a $74.00 price... More of this article »
Image about Terex (NYSE:TEX) Downgraded by JPMorgan Chase & Co. to Neutral

Terex (NYSE:TEX) Downgraded by JPMorgan Chase & Co. to Neutral

JPMorgan Chase & Co. downgraded shares of Terex (NYSE:TEX – Free Report) from an overweight rating to a neutral rating in a report published on Monday, MarketBeat reports. JPMorgan Chase & Co. currently has $63.00 target... More of this article »
Image about Hudson Pacific Properties (NYSE:HPP) Upgraded to “Outperform” at Wolfe Research

Hudson Pacific Properties (NYSE:HPP) Upgraded to “Outperform” at Wolfe Research

Wolfe Research upgraded shares of Hudson Pacific Properties (NYSE:HPP – Free Report) from a peer perform rating to an outperform rating in a research report report published on Monday morning, MarketBeat reports. Wolfe Research... More of this article »
Image about NexPoint Residential Trust (NYSE:NXRT) Downgraded to “Underperform” at Raymond James

NexPoint Residential Trust (NYSE:NXRT) Downgraded to “Underperform” at Raymond James

Raymond James lowered shares of NexPoint Residential Trust (NYSE:NXRT – Free Report) from a market perform rating to an underperform rating in a report issued on Monday, MarketBeat.com reports. Several other research firms have... More of this article »
Image about IN8bio (NASDAQ:INAB) Receives New Coverage from Analysts at Laidlaw

IN8bio (NASDAQ:INAB) Receives New Coverage from Analysts at Laidlaw

Laidlaw initiated coverage on shares of IN8bio (NASDAQ:INAB – Free Report) in a report published on Monday, Marketbeat Ratings reports. The brokerage issued a buy rating and a $7.50 price target on the stock. IN8bio Stock Performance Shares... More of this article »
Image about Amylyx Pharmaceuticals (NASDAQ:AMLX) Lowered to “Neutral” at Mizuho

Amylyx Pharmaceuticals (NASDAQ:AMLX) Lowered to “Neutral” at Mizuho

Mizuho lowered shares of Amylyx Pharmaceuticals (NASDAQ:AMLX – Free Report) from a buy rating to a neutral rating in a research note published on Monday, Marketbeat.com reports. Other analysts also recently issued research reports... More of this article »
Image about BlackLine (NASDAQ:BL) Receives New Coverage from Analysts at Wolfe Research

BlackLine (NASDAQ:BL) Receives New Coverage from Analysts at Wolfe Research

Wolfe Research started coverage on shares of BlackLine (NASDAQ:BL – Free Report) in a research note released on Monday morning, MarketBeat.com reports. The firm issued a peer perform rating on the technology company’s stock. Several... More of this article »
Image about Paramount Group (NYSE:PGRE) Upgraded to “In-Line” at Evercore ISI

Paramount Group (NYSE:PGRE) Upgraded to “In-Line” at Evercore ISI

Evercore ISI upgraded shares of Paramount Group (NYSE:PGRE – Free Report) from an underperform rating to an in-line rating in a research report sent to investors on Monday, Marketbeat Ratings reports. They currently have $5.00... More of this article »
Image about SL Green Realty (NYSE:SLG) Lowered to Underperform at Evercore ISI

SL Green Realty (NYSE:SLG) Lowered to Underperform at Evercore ISI

Evercore ISI downgraded shares of SL Green Realty (NYSE:SLG – Free Report) from an in-line rating to an underperform rating in a report issued on Monday morning, MarketBeat reports. The firm currently has $44.00 target price... More of this article »
Image about Gladstone Commercial (NASDAQ:GOOD) Now Covered by Analysts at Alliance Global Partners

Gladstone Commercial (NASDAQ:GOOD) Now Covered by Analysts at Alliance Global Partners

Alliance Global Partners started coverage on shares of Gladstone Commercial (NASDAQ:GOOD – Free Report) in a report issued on Monday, Marketbeat.com reports. The brokerage issued a buy rating and a $15.50 target price on the... More of this article »